Lentiviral Vector as a Drug Product- a Gene Therapy Vector Facility Case Study
12:10 pm - Thursday 26th February 2026
- Introducing Kings College London's Gene Therapy Vector Facility
- Manufacturing lentiviral vectors as a drug product
- Highlighting GTVFs CDMO offerings